Kayne Anderson Rudnick Investment recently announced the acquisition of new stake in U.S. Physical Therapy Inc. (NYSE:USPH). The institutional investor has increased its shareholding in the Healthcare company by 2.10% to 1.54 million shares with purchase of 31732.0 shares. This fresh investment now brings its stake to 11.86% valued currently at $124.96 million. In addition, T. Rowe Price Investment Manageme raised its holdings by 0.91 million to 0.91 million shares. And The Vanguard Group, Inc. has lifted its position by 0.09% or 798.0 shares – to 0.91 million shares.
With over 0.1 million U.S. Physical Therapy Inc. (USPH) shares trading Monday and a closing price of $95.93 on the day, the dollar volume was approximately $9.9 million. The shares have shown a negative half year performance of -23.20% and its price on 01/23/23 gained nearly 1.79%. Currently, there are 13.00M common shares owned by the public and among those 12.75M shares have been available to trade.
Insiders at the company have transacted a total of 44 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 58,400 shares. Insider sales of the common stock occurred on 28 occasions, with total insider shares sold totaling 61,928 shares.
The top 3 mutual fund holders in U.S. Physical Therapy Inc. are Virtus KAR Small Cap Growth Fund, iShares Core S&P Small Cap ETF, and Calvert Small Cap Fund. Virtus KAR Small Cap Growth Fund owns 1.19 million shares of the company’s stock, all valued at over $96.02 million. iShares Core S&P Small Cap ETF sold 7578.0 shares to see its total holdings shrink to 0.96 million shares valued at over $77.99 million and representing 7.40% of the shares outstanding. Calvert Small Cap Fund bought 4243.0 shares to bring its total holdings to over 0.46 million shares at a value of $37.27 million. Calvert Small Cap Fund now owns shares totaling to 3.54% of the shares outstanding.
Shares of U.S. Physical Therapy Inc. (NYSE: USPH) opened at $94.29, up $0.05 from a prior closing price of $94.24. However, the script later moved the day high at 96.83, up 1.79%. The company’s stock has a 5-day price change of 7.01% and 19.85% over the past three months. USPH shares are trading 18.39% year to date (YTD), with the 12-month market performance up to 5.70% higher. It has a 12-month low price of $73.30 and touched a high of $131.50 over the same period. USPH has an average intraday trading volume of 79.32K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 12.93%, 12.15%, and 1.25% respectively.
Institutional ownership of U.S. Physical Therapy Inc. (NYSE: USPH) 13.00M shares outstanding. Mutual fund holders own 6.37%, while other institutional holders and individual stakeholders account for 63.45% and 43.24% respectively.
It has a market capitalization of $1.22B and a beta (3y monthly) value of 1.30. The stock’s trailing 12-month PE ratio is 32.08, while the earnings-per-share (ttm) stands at $2.99. The company has a PEG of 3.21 and a Quick Ratio of 1.40 with the debt-to-equity ratio at 0.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.11% over the week and 3.01% over the month.
Analysts forecast that U.S. Physical Therapy Inc. (USPH) will achieve an EPS of $0.56 for the current quarter, $0.6 for the next quarter and $2.97 for 2023. The lowest estimate earnings-per-share for the quarter is $0.48 while analysts give the company a high EPS estimate of $0.6. Comparatively, EPS for the current quarter was $0.85 a year ago. Earnings per share for the fiscal year are expected to decrease by -2.50%, and 8.28% over the next financial year. EPS should grow at an annualized rate of 10.00% over the next five years, compared to 8.00% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 4 brokerage firm advisors rate U.S. Physical Therapy Inc. (USPH) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 2 of the 4 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the USPH, a number of firms have released research notes about the stock. CJS Securities stated their Market Outperform rating for the stock in a research note on December 14, 2021, with the firm’s price target at $120. Barrington Research coverage for the U.S. Physical Therapy Inc. (USPH) stock in a research note released on August 06, 2021 offered a Outperform rating with a price target of $139. Barrington Research was of a view on May 07, 2021 that the stock is Outperform, while Jefferies gave the stock Buy rating on May 03, 2021, issuing a price target of $130- $135. Barrington Research on their part issued Mkt Perform rating on February 26, 2021.